NYSE:COO - Cooper Companies Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$247.99 +1.20 (+0.49 %)
(As of 07/19/2018 04:00 PM ET)
Previous Close$246.79
Today's Range$244.58 - $248.28
52-Week Range$216.47 - $260.26
Volume347,400 shs
Average Volume456,797 shs
Market Capitalization$12.08 billion
P/E Ratio25.57
Dividend Yield0.02%
Cooper Companies logoThe Cooper Companies, Inc. operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia. It also provides range of products and services focusing on women's health, including medical devices, fertility, genomics, and diagnostics and contraception for hospitals and surgical centers, obstetricians' and gynecologists' (ob/gyns) medical offices, and fertility clinics. In addition, the company offers carrier screening, preimplantation genetic screening, and preimplantation genetic diagnosis used in IVF process; IVF medical devices, systems, and equipment; and PARAGARD, a non-hormonal, copper intrauterine device for birth control. Further, The Cooper Companies, Inc. offers its products under Biofinity, clarity 1day, MyDay, and Proclear 1 Day brand name. The company markets its products through a network of field sales representatives, independent agents, and distributors. The Cooper Companies, Inc. was founded in 1980 and is headquartered in Pleasanton, California.

Receive COO News and Ratings via Email

Sign-up to receive the latest news and ratings for COO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Ophthalmic goods
Sub-IndustryHealth Care Supplies


Debt-to-Equity Ratio0.77
Current Ratio2.76
Quick Ratio1.67


Trailing P/E Ratio25.57
Forward P/E Ratio20.98
P/E Growth1.94

Sales & Book Value

Annual Sales$2.14 billion
Price / Sales5.69
Cash Flow$13.7849 per share
Price / Cash17.99
Book Value$64.88 per share
Price / Book3.82


EPS (Most Recent Fiscal Year)$9.70
Net Income$372.90 million
Net Margins5.58%
Return on Equity17.14%
Return on Assets9.68%


Outstanding Shares49,100,000
Market Cap$12,083.05

Cooper Companies (NYSE:COO) Frequently Asked Questions

What is Cooper Companies' stock symbol?

Cooper Companies trades on the New York Stock Exchange (NYSE) under the ticker symbol "COO."

How often does Cooper Companies pay dividends? What is the dividend yield for Cooper Companies?

Cooper Companies announced a semiannual dividend on Friday, July 13th. Stockholders of record on Monday, July 23rd will be paid a dividend of $0.03 per share on Tuesday, August 7th. This represents a dividend yield of 0.02%. The ex-dividend date is Friday, July 20th. View Cooper Companies' Dividend History.

How will Cooper Companies' stock buyback program work?

Cooper Companies announced that its Board of Directors has initiated a share repurchase plan on Friday, April 7th 2017, which authorizes the company to buyback $500,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to purchase up to 5.2% of its stock through open market purchases. Stock buyback plans are usually a sign that the company's board of directors believes its stock is undervalued.

How were Cooper Companies' earnings last quarter?

Cooper Companies Inc (NYSE:COO) released its earnings results on Thursday, June, 7th. The medical device company reported $2.86 EPS for the quarter, beating analysts' consensus estimates of $2.84 by $0.02. The medical device company earned $631.30 million during the quarter, compared to analysts' expectations of $627.49 million. Cooper Companies had a net margin of 5.58% and a return on equity of 17.14%. Cooper Companies's revenue for the quarter was up 20.8% compared to the same quarter last year. During the same quarter last year, the firm earned $2.50 EPS. View Cooper Companies' Earnings History.

When is Cooper Companies' next earnings date?

Cooper Companies is scheduled to release their next quarterly earnings announcement on Wednesday, August, 29th 2018. View Earnings Estimates for Cooper Companies.

What guidance has Cooper Companies issued on next quarter's earnings?

Cooper Companies issued an update on its FY18 earnings guidance on Thursday, June, 7th. The company provided earnings per share guidance of $11.70-11.90 for the period, compared to the Thomson Reuters consensus EPS estimate of $11.79. The company issued revenue guidance of $2.52-2.55 billion, compared to the consensus revenue estimate of $2.53 billion.

What price target have analysts set for COO?

12 brokerages have issued 1-year target prices for Cooper Companies' shares. Their predictions range from $231.00 to $285.00. On average, they expect Cooper Companies' stock price to reach $265.40 in the next twelve months. This suggests a possible upside of 7.0% from the stock's current price. View Analyst Ratings for Cooper Companies.

What is the consensus analysts' recommendation for Cooper Companies?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cooper Companies in the last year. There are currently 6 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Who are some of Cooper Companies' key competitors?

Who are Cooper Companies' key executives?

Cooper Companies' management team includes the folowing people:
  • Mr. Albert G. White III, Pres, CEO & Director (Age 48)
  • Mr. Daniel G. McBride Esq., Chief Operating Officer, Exec. VP and Pres of CooperVision Inc (Age 54)
  • Mr. Agostino Ricupati, Chief Accounting Officer and Sr. VP of Fin. & Tax
  • Ms. Carol R. Kaufmann, Advisor (Age 69)
  • Mr. Brian Andrews, Sr. VP, CFO & Treasurer

Has Cooper Companies been receiving favorable news coverage?

Media stories about COO stock have been trending somewhat negative recently, Accern Sentiment reports. The research group identifies positive and negative news coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Cooper Companies earned a news sentiment score of -0.15 on Accern's scale. They also assigned media coverage about the medical device company an impact score of 48.72 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the next several days.

Who are Cooper Companies' major shareholders?

Cooper Companies' stock is owned by a number of of institutional and retail investors. Top institutional investors include GENERATION INVESTMENT MANAGEMENT LLP (5.20%), Handelsbanken Fonder AB (0.74%), Fisher Asset Management LLC (0.21%), NN Investment Partners Holdings N.V. (0.15%), Westpac Banking Corp (0.14%) and James Hambro & Partners (0.09%). Company insiders that own Cooper Companies stock include A Thomas Bender, Albert G White III, Allan E Rubenstein, Carol R Kaufman, Daniel G Mcbride, Gary S Petersmeyer, Jody S Lindell, Michael Kalkstein, Paul L Remmell, Randal Golden, Robert S Weiss, Stanley Md Zinberg and William A Kozy. View Institutional Ownership Trends for Cooper Companies.

Which institutional investors are selling Cooper Companies stock?

COO stock was sold by a variety of institutional investors in the last quarter, including NN Investment Partners Holdings N.V., Fisher Asset Management LLC, Hartford Investment Management Co., Municipal Employees Retirement System of Michigan, Huntington National Bank, Amalgamated Bank, Retirement Systems of Alabama and Denali Advisors LLC. Company insiders that have sold Cooper Companies company stock in the last year include A Thomas Bender, Allan E Rubenstein, Carol R Kaufman, Daniel G Mcbride, Gary S Petersmeyer, Michael Kalkstein, Robert S Weiss and Stanley Md Zinberg. View Insider Buying and Selling for Cooper Companies.

Which institutional investors are buying Cooper Companies stock?

COO stock was bought by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Handelsbanken Fonder AB, Nisa Investment Advisors LLC, James Hambro & Partners, Westpac Banking Corp, Gateway Investment Advisers LLC, Contravisory Investment Management Inc. and Bellecapital International Ltd.. View Insider Buying and Selling for Cooper Companies.

How do I buy shares of Cooper Companies?

Shares of COO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cooper Companies' stock price today?

One share of COO stock can currently be purchased for approximately $247.99.

How big of a company is Cooper Companies?

Cooper Companies has a market capitalization of $12.08 billion and generates $2.14 billion in revenue each year. The medical device company earns $372.90 million in net income (profit) each year or $9.70 on an earnings per share basis. Cooper Companies employs 11,800 workers across the globe.

How can I contact Cooper Companies?

Cooper Companies' mailing address is 6140 Stoneridge Mall Road Suite 590, PLEASANTON CA, 94588. The medical device company can be reached via phone at 925-460-3600 or via email at [email protected]

MarketBeat Community Rating for Cooper Companies (NYSE COO)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  381 (Vote Outperform)
Underperform Votes:  336 (Vote Underperform)
Total Votes:  717
MarketBeat's community ratings are surveys of what our community members think about Cooper Companies and other stocks. Vote "Outperform" if you believe COO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe COO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/19/2018 by MarketBeat.com Staff

Featured Article: Earnings Per Share

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.